Artemis Medicare Services Limited has made a regulatory disclosure pursuant to Regulation 30 of SEBI Listing Regulations, following up on their previous intimation dated February 2, 2026.
The Board of Directors of the Company, at its meeting held on June 4, 2026, approved seeking shareholder approval through postal ballot for raising funds up to ₹700 crores (Rupees Seven Hundred Crores Only).
The fundraise will be conducted through the issuance of Equity Shares and/or other eligible securities to permitted investors, in accordance with:
- Companies Act, 2013 and rules made thereunder
- Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 (as amended)
- Any other applicable laws
The specific manner, terms, and conditions of the issuance will be determined at the absolute discretion of the Board of Directors or its committee.
The approval is subject to receipt of necessary regulatory and statutory approvals as may be required.
The Board has approved the draft Postal Ballot Notice, and the Company will seek shareholder approval through Postal Ballot in accordance with applicable provisions/circulars issued by the Ministry of Corporate Affairs.
The Postal Ballot Notice will be circulated to members in due course as per applicable laws.
The Board meeting commenced at 4:30 PM and concluded at 6:00 PM on June 4, 2026.
Financial impact not quantified in the disclosure beyond the maximum fundraise amount of ₹700 crores.